BIOVIA solutions create an unmatched scientific innovation environment that can help science- and process-driven companies develop better products faster and more cost effectively. The industry-leading BIOVIA portfolio integrates the diversity of science, experimental processes and information requirements from discovery to manufacturing with proven capabilities in Scientific Informatics, Molecular Modeling & Simulation, Data Science, Laboratory Informatics, Formulation Design, Quality & Compliance and Manufacturing Analytics. BIOVIA solutions are used by more than 2,000 companies in the Life Sciences, Chemistry, Oil & Gas, Consumer Packaged Goods, Transportation & Mobility, Aerospace & Defense, High-Tech and Industrial Equipment sectors, as well as academic and government entities. Customers include 25 of the top 25 pharmaceutical companies, 25 of the top 25 biotech companies, 20 of the top 25 chemical companies, 4 of the top 5 consumer packaged goods companies, 7 of the top 10 oil and gas companies and 3 of the top 5 aerospace companies.
External link for BIOVIA
5005 Wateridge Vista Drive
San Diego, CA 92121, US
334 Cambridge Science Park
Cambridge, CB4 0WN, GB
Excited to partner with Bel on advancing sustainability through #AI!
🎉 We’re excited to announce a long-term partnership with Bel, you may know them for their iconic brands such as The Laughing Cow and Babybel. 😱 Together, we will work to accelerate the food industry’s transition towards a more sustainable model by digitalizing the end-to-end value chain and leveraging AI for innovation. Read more: http://go.3ds.com/nEp
Need a new ELN but don’t know where to start? Let us help you get “unstuck”. Selecting the right ELN strategy and solution can give your organization a competitive edge and help drive your productivity for years to come. Download this comprehensive whitepaper to discover 7 essential tips that will help propel your R&D efforts forward: http://go.3ds.com/Zj8.
AlphaFold/OpenFold has revolutionized drug discovery with the ability to predict how proteins fold based on their amino acid sequences. However, many proteins are either partially folded or do not fold at all. These intrinsically disordered proteins (IDPs) are implicated in several complex diseases, including cancer, cardiovascular or neurodegenerative diseases. Despite advances in #AI and #ML, accurate prediction of the structures of IDPs is still challenging due to insufficient training data. Using BIOVIA Pipeline Pilot, Dr. David Kombo from the Medicinal Chemistry Department at Sanofi and his collaborators at Cornell University were able to reliably differentiate between folded proteins and IDPs by applying AI/ML to protein dynamics based on the bioinformatic representation of amino acid sequences. To learn more, read their recent publication here: https://lnkd.in/gg8ZGNAp.
How can Large Language Models (LLMs) enhance the onboarding process? BIOVIA #PipelinePilot's user-friendly interface leverages #AI-driven workflows and advanced analytics, enabling scientists at all career stages to utilize data effectively without needing programming expertise. However, getting started with any new tool can be time-consuming. In our latest blog by Dr. Mark Spillman, we demonstrate how on-demand expert assistance using LLMs can streamline the process of Pipeline Pilot protocol design and execution. Learn more about this integration here: http://go.3ds.com/OPq.
“It’s the right place with the right people for knowledge sharing and problem-solving alongside brilliant minds,” said one of the attendees of BIOVIA Live Americas. 📢Registration is now open for BIOVIA Live Europe! Join us and your industry peers in London, UK, October 15-17, learn more and register here: https://lnkd.in/gf6psWfR. #BIOVIALive2024
🎉 What a whirlwind at Future Labs Live Basel! Our team had some great conversations about all things ONE Lab, Generative Therapeutics Design (GTD) and Discovery Studio. Thanks to everyone who stopped by our booth and joined us for the reception. 👥 Connect with us to keep the conversation going.
Automate Batch Release for Faster Results. Why spend time manually reviewing and approving every batch release test result, when the process can be automated? BIOVIA #ONELab's innovative Automated Review-by-Exception can reduce approval time by up to 80%. By eliminating manual signature processes, it dramatically accelerates the entire workflow. Discover how to optimize your batch release process: http://go.3ds.com/Pgz.
The APQR process is often laborious, time-consuming and resource-intensive. However, pharmaceutical companies can meet regulatory requirements while streamlining their processes and driving continuous improvement by adopting innovative approaches like Structured Document Authoring – APQR. Delve deeper into the essence of streamlining APQR processes in this whitepaper: http://go.3ds.com/g4r.
Have you registered for #BIOVIALive2024 Europe? Join us and your industry peers at this premier 3-day scientific event in London, UK, from October 15-17. Explore 70+ sessions across 5 tracks, including: - AI-Driven Drug Discovery - Machine Learning in Materials Innovation - AI/ML Use Cases with Pipeline Pilot - Data Science and AI Advancements in Biopharma Discover the detailed agenda and register here: http://go.3ds.com/I0O.
Let your voice be your lab assistant! 🗣️ We are excited to announce our partnership with ASCENSCIA - Lab Voice Assistant, a leading voice assistant software provider, to integrate #AI voice technology into BIOVIA’s unified lab solution for drug discovery and development (ONE Lab, Workbook and Notebook ELNs). With simple voice commands, ASCENSCIA enables users to record and transcribe voice notes, navigate protocols, take photos, set timers and locate samples. Discover how our collaboration enhances your study efficiency and reproducibility: http://go.3ds.com/oyJ.